SOUTH SAN FRANCISCO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to ...

A massive protest was held on Friday by members of the Shri Gudedevasthana Lift Irrigation Project Victim Farmers’ Federation ...

Today we look at two noteworthy recent insider buys. On Monday, Alumis', Srinivas Akkaraju, made a $1.48M purchase of ALMS, buying 320,290 shares at a cost of $4.61 each. Alumis is trading up ...

Alumis Inc. (NASDAQ:ALMS), listed on NASDAQ and part of the top nasdaq stocks, operates in the clinical-stage biopharmaceutical sector.

Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of ...

DALLAS--(BUSINESS WIRE)--Aldous Law Firm, a premier personal injury boutique, is pleased to announce that ALM and Law.com have included the firm’s $71.95 million verdict in an industrial ...

Head Noor Achmad emphasized that the agency has launched a range of programs aimed at empowering citizens across the ...